Relapse of giant cell myocarditis supported with veno-arterial extracorporeal membrane oxygenation

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 5, 2011, Pages 829-831

  Yeen, Wing C ^a   Haas, Garrie ^a   Mehmood, Syed A ^a   Crestanello, Juan A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Extracorporeal membrane oxygenation; Giant cell myocarditis

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISONE; RAPAMYCIN; THYMOCYTE ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CARDIOVERSION; CASE REPORT; DEFIBRILLATOR; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; INTERSTITIAL MYOCARDITIS; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; RENAL REPLACEMENT THERAPY; ULCERATIVE COLITIS;

ADULT; BIOPSY; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; GIANT CELLS; HEART FAILURE; HEMODYNAMICS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDITIS; MYOCARDIUM; NECROSIS; RECURRENCE; TREATMENT OUTCOME; VENTRICULAR FUNCTION;

EID: 79956204801     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.250035     Document Type: Article

References (10)

1. Cooper LT Jr. Giant cell myocarditis: diagnosis and treatment. Herz 2000;25:291-298.
2. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis -natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997;336:1860-1866.
3. Taylor DO, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Rahmel AO, Kucheryavaya AY, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth Official Adult Heart Transplant Report-2008. J Heart Lung Transplant 2008;27:943-956.
4. Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW, Giant Cell Myocarditis Treatment Trial Investigators. Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 2008; 102:1535-1539.
5. Acker MA. Mechanical circulatory support for patients with acutefulminant myocarditis. Ann Thorac Surg 2001;71:S73-S76.
6. Marelli D, Kermani R, Bresson J, Fishbein MC, Hamilton M, Moriguchi J, Fonarow GC, Cohen B, Kobashigawa J, Laks H. Support with the BVS 5000 assist device during treatment of acute giant-cell myocarditis. Tex Heart Inst J 2003;30:50-56.
7. Schenk S, Arusoglu L, Morshuis M, Minami K, Sarnowski P, Koerfer R, El-Banayosy A. Triple bridge-to-transplant in a case of giant cell myocarditis complicated by human leukocyte antigen sensitization and heparin-induced thrombocytopenia type II. Ann Thorac Surg 2006; 81:1107-1109.
8. Davies RA, Veinot JP, Smith S, Struthers C, Hendry P, Masters R. Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome. J Heart Lung Transplant 2002;21:674-679.
9. Ankersmit HJ, Ullrich R, Moser B, Hoetzenecker K, Hacker S, German P, Krenn C, Horvat R, Grimm M, Wolner E, Zuckermann A. Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. Thorac Cardiovasc Surg 2006;54:278-280.
10. Murashita T, Sugiki T, Tachibana T, Kunihara T, Sugiki H. A case of giant cell myocarditis: bridge to recovery by long-term mechanical circulatory support without immunosuppressive therapy. J Thorac Cardiovasc Surg 2006;132:432-433.